9 participants
A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-25
- Start Date:
- 2025-06-04
- Completion:
- 2028-05-31
Conditions
- Chronic Graft-versus-host-disease
Interventions
- DRUG
No Results Yet